Bangladesh, Nov. 3 -- The leading drug makers posted double-digit profit growth year-on-year in FY26, supported by strong sales amid sustained demand for medicines both at home and abroad.
Advertisement
Sales of lifesaving drugs increased due to strong local demand, while leading companies successfully managed to keep operating costs down, securing higher bottom-line growth, say industry insiders.
The sector's performance stands out at a time when most other industries, including multinational companies, are grappling with elevated energy costs amid persistent inflationary pressure.
The growing population, coupled with rising awareness of healthcare needs, has amplified demand for generic medicines in the local market, particularly for c...